David Laharie

43PUBLICATIONS
68CO-AUTHORS
Other European languagesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Rheumatology and arthritisMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Sep 28, 2026
Persistence, Safety and Pharmacokinetics of Vedolizumab After Switching to the Subcutaneous Route in a Prospective French National Cohort Study.

|Sep 12, 2026
Acceptability and tolerability of risankizumab maintenance therapy administered via on-body injector in patients with Crohn's disease: Results of the ACCEPT-OBI study.

|Jul 24, 2026
Ustekinumab for fistulising perianal Crohn's disease: a randomised placebo-controlled trial from the GETAID.

|May 09, 2026
Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis.

|May 01, 2026
The GETAID: over 40 years of academic research in IBD.

|Apr 27, 2026
One-Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real-World GETAID Study.

Pageof 8

Frequent Collaborators

16 joint publications

Laurent Peyrin-Biroulet

12 joint publications

Guillaume Bouguen

11 joint publications

Aurelien Amiot

9 joint publications

Xavier Roblin